Literature DB >> 17426168

Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide.

Rami M Mukbel1, Calvin Patten, Katherine Gibson, Mousumi Ghosh, Christine Petersen, Douglas E Jones.   

Abstract

The requirements for effective and efficient intracellular killing of Leishmania amazonensis by activated macrophages are unknown. Despite resistance to the arginase inhibitor LOHA by intracellular L. amazonensis amastigotes, enhanced replication did not account for the relative resistance of this parasite to macrophage activation. Herein we report that the presence of both superoxide and nitric oxide is necessary for efficient killing of L. amazonensis amastigotes within LPS/IFN-gamma-activated bone marrow-derived macrophages generated from C3H mice. Addition of an extracellular signal-regulated kinase (ERK) inhibitor to L. amazonensis-infected macrophages increased the ability of these activated macrophages to kill L. amazonensis amastigotes. This enhanced macrophage killing through addition of ERK inhibitor was abrogated by inhibition of superoxide or iNOS, whereas inhibiting superoxide had no effect on the killing of L. major. These results suggest that ERK activation may modulate effective macrophage killing, leading to the ability of L. amazonensis to resist elimination within activated macrophages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426168

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  53 in total

1.  Immunomodulatory and Antileishmanial Activity of Phenylpropanoid Dimers Isolated from Nectandra leucantha.

Authors:  Thais Alves da Costa-Silva; Simone S Grecco; Fernanda S de Sousa; João Henrique G Lago; Euder G A Martins; César A Terrazas; Sanjay Varikuti; Katherine L Owens; Stephen M Beverley; Abhay R Satoskar; Andre G Tempone
Journal:  J Nat Prod       Date:  2015-04-02       Impact factor: 4.050

2.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

3.  IL-2 limits IL-12 enhanced lymphocyte proliferation during Leishmania amazonensis infection.

Authors:  Amanda E Ramer-Tait; Christine A Petersen; Douglas E Jones
Journal:  Cell Immunol       Date:  2011-04-09       Impact factor: 4.868

Review 4.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

5.  Intralesional uridine-5'-triphosphate (UTP) treatment induced resistance to Leishmania amazonensis infection by boosting Th1 immune responses and reactive oxygen species production.

Authors:  Camila Marques-da-Silva; Mariana M Chaves; Maria Luiza Thorstenberg; Vanessa R Figliuolo; Flávia S Vieira; Suzana P Chaves; José Roberto Meyer-Fernandes; Bartira Rossi-Bergmann; Luiz Eduardo Baggio Savio; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2018-04-21       Impact factor: 3.765

6.  Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.

Authors:  C Ricardo-Carter; M Favila; R E Polando; R N Cotton; K Bogard Horner; D Condon; W Ballhorn; J P Whitcomb; M Yadav; R L Geister; J S Schorey; M A McDowell
Journal:  Parasite Immunol       Date:  2013-12       Impact factor: 2.280

7.  Human and mouse macrophages collaborate with neutrophils to kill larval Strongyloides stercoralis.

Authors:  Sandra Bonne-Année; Laura A Kerepesi; Jessica A Hess; Amy E O'Connell; James B Lok; Thomas J Nolan; David Abraham
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

8.  Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania.

Authors:  Djalma S Lima-Junior; Diego L Costa; Vanessa Carregaro; Larissa D Cunha; Alexandre L N Silva; Tiago W P Mineo; Fredy R S Gutierrez; Maria Bellio; Karina R Bortoluci; Richard A Flavell; Marcelo T Bozza; João S Silva; Dario S Zamboni
Journal:  Nat Med       Date:  2013-06-09       Impact factor: 53.440

9.  Targeted extracellular signal-regulated kinase activation mediated by Leishmania amazonensis requires MP1 scaffold.

Authors:  Paola M Boggiatto; Pedro A Martinez; Ashok Pullikuth; Douglas E Jones; Bryan Bellaire; Andrew Catling; Christine Petersen
Journal:  Microbes Infect       Date:  2014-01-22       Impact factor: 2.700

10.  Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK.

Authors:  Paola Mercedes Boggiatto; Fei Jie; Mousumi Ghosh; Katherine Nicole Gibson-Corley; Amanda Ellen Ramer-Tait; Douglas Elliot Jones; Christine Anne Petersen
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.